Keyphrases
Programmed Death-ligand 1 (PD-L1)
63%
T Cells
63%
Type I Diabetes
48%
Type 1 Diabetes Mellitus (T1DM)
48%
Autoimmunity
42%
Autoimmune Diabetes
34%
CD8+ T Cells
33%
CD4+ T Cells
31%
Experimental Autoimmune Encephalomyelitis
25%
Insulin
24%
T Cell Activation
24%
Central Nervous System
22%
Dendritic Cells
22%
Islet
18%
Regulatory T Cells
18%
NOD Mice
17%
Programmed death-1 Pathway
17%
CD4+
16%
B Cells
16%
MHC Class II
16%
Regulatory T (Treg) Cells
16%
Diabetes
16%
Graft-versus-host Disease (GvHD)
15%
Chemokines
14%
CD4 T Cells
14%
Treg
14%
CD4+ T
13%
Non-obese Diabetic Mice
12%
Mast Cells
11%
Tactile Sensitivity
11%
Cellular Accumulation
9%
Chemokine Receptor
9%
Autoreactive
9%
Anergy
8%
Self-assembling Peptide
8%
Programmed Death-ligand 1 Expression
8%
Self-reactivity
8%
Lethality
8%
Peripheral Tolerance
8%
Resident Memory T Cells
7%
Hapten
7%
Chemokine (C-C motif) Ligand 2 (CCL2)
7%
Acute Pancreatitis
7%
Interleukin-12 (IL-12)
7%
Leukocytes
7%
Influenza
7%
T-cell Mediated
7%
PD-L2
7%
Tumor
7%
Autoimmune Disease
7%
Immunology and Microbiology
T Cell
100%
T-Helper Cell
59%
Autoimmunity
44%
Regulatory T Cell
32%
Cytotoxic T-Cell
32%
Autoimmune Diabetes
31%
Peptides
30%
Insulin
30%
Nonobese Diabetic Mouse
28%
Central Nervous System
27%
Experimental Autoimmune Encephalomyelitis
25%
Programmed Death-Ligand 1
23%
Programmed Death 1 Ligand 1
19%
T Cell Receptor
19%
Dendritic Cell
19%
Antigen Specificity
18%
B Cell
18%
Immune Tolerance
18%
Chemokine
18%
Graft-Versus-Host Disease
15%
Cell Function
13%
Lymph Node
11%
MHC Class II
11%
CD4
10%
Clinically Isolated Syndrome
10%
Immunocompetent Cell
10%
T Cell Activation
9%
Chemokine Receptor
9%
Cell Population
9%
Macrophage
9%
CTLA-4
8%
Memory T Cell
8%
Leukocyte
8%
CD28
8%
T Cell Subset
7%
Theiler's Murine Encephalomyelitis Virus
7%
CC Chemokine Receptors
7%
Mast Cell
7%
Influenza
7%
Cell Migration
7%
CD8
7%
Autoimmune Disease
7%
CD25
6%
Agonist
6%
Pancreas
6%
Autoantibodies
6%
Transgenic Mouse
6%
Cell Differentiation
6%
T-Cell Tolerance
5%
Antigen-Presenting Cell
5%
